Skip to content
Dx

ICD-10-CM 2027 diagnosis code

D89.83Cytokine release syndrome

Not billable — use a more specific code

D89.83 is a header code, so it can't be reported by itself. Choose one of the 6 more specific codes beneath it.

Code last changed in FY2021 (effective October 1, 2020). Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About D89.83

D89.83 is the ICD-10-CM diagnosis code for Cytokine release syndrome. It belongs to category D89 (other disorders involving the immune mechanism, not elsewhere classified), block D80-D89 (certain disorders involving the immune mechanism) and chapter 3 (diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism). It is a header code, so it can't be reported by itself; one of its 6 subcodes must be used instead.

Within D89.8 (other specified disorders involving the immune mechanism, not elsewhere classified), D89.83 is specifically for Cytokine release syndrome. Related codes cover graft-versus-host disease (D89.81), autoimmune lymphoproliferative syndrome [ALPS] (D89.82), IgG4-related disease (D89.84) and other specified disorders involving the immune mechanism, not elsewhere classified (D89.89).

To report this condition, pick the subcode that matches the documentation: D89.831 (grade 1), D89.832 (grade 2), D89.833 (grade 3), D89.834 (grade 4), D89.835 (grade 5) and D89.839 (grade unspecified).

Code first underlying cause, such as: complications following infusion, transfusion and therapeutic injection (T80.89-) and complications of transplanted organs and tissue (T86.-).

Use an additional code for adverse effect, if applicable, to identify immune checkpoint inhibitors and immunostimulant drugs (T45.AX5). Use an additional code to identify associated manifestations.

It was added in FY2021, effective October 1, 2020.

Specific codes under D89.83

Coding notes

Code firstSequence the underlying condition first
  • underlying cause, such as:
  • complications following infusion, transfusion and therapeutic injection (T80.89-)
  • complications of transplanted organs and tissue (T86.-)
Use additional codeAdd a secondary code to fully describe the condition
  • code for adverse effect, if applicable, to identify immune checkpoint inhibitors and immunostimulant drugs (T45.AX5)
  • code to identify associated manifestations

Notes that apply from higher levels

Instructions written at a parent level also apply to D89.83.

› From D89 Other disorders involving the immune mechanism, not elsewhere classified
Excludes1
  • hyperglobulinemia NOS (R77.1)
  • monoclonal gammopathy (of undetermined significance) (D47.2)
Excludes2
  • transplant failure and rejection (T86.-)

Broader instructions also apply from D80-D89 Certain disorders involving the immune mechanism and Chapter 3: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism.

Codes whose notes reference D89.83

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2021 (effective 10/1/2020): Added
  • No changes since FY2021.

Common questions about D89.83

Is D89.83 billable?

No. D89.83 is a header code. Report one of its more specific subcodes instead.